![](/img/cover-not-exists.png)
OP42 PHARMACODYNAMIC (PD) DIFFERENCES BETWEEN CANAGLIFLOZIN (CANA) 300 MG AND DAPAGLIFLOZIN (DAPA) 10 MG FOR URINARY GLUCOSE EXCRETION (UGE), RENAL THRESHOLD FOR GLUCOSE (RTG), AND POSTPRANDIAL PLASMA GLUCOSE (PPG) EXCURSION IN HEALTHY PARTICIPANTS
Sha, S., Polidori, D., Farrell, K., Ghosh, A., Natarajan, J., Vaccaro, N., Pinheiro, J., Rothenberg, P., Plum-Mörschel, L.Volume:
106
Language:
english
Journal:
Diabetes Research and Clinical Practice
DOI:
10.1016/S0168-8227(14)70248-7
Date:
November, 2014
File:
PDF, 77 KB
english, 2014